The latest price target for Exelixis (NASDAQ:EXEL) was reported by BMO Capital on December 20, 2024. The analyst firm set a price target for $40.00 expecting EXEL to rise to within 12 months (a possible 22.32% upside). 33 analyst firms have reported ratings in the last year.

The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by BMO Capital, and Exelixis downgraded their market perform rating.

There is no last upgrade for Exelixis

The last downgrade for Exelixis Inc happened on December 20, 2024 when BMO Capital changed their price target from $36 to $40 for Exelixis Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.

While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a downgraded with a price target of $36.00 to $40.00. The current price Exelixis (EXEL) is trading at is $32.70, which is out of the analyst’s predicted range.